The Eighth Annual Conference of the American Society ical trial using human embryonic dopaminergic cell transplants in patients with Parkinson's disease were pub-for Neural Transplantation and Repair (ASNTR) was held May 3-6, 2001 in Clearwater Beach, Florida. In lished by Curt Freed's group. The results from this trial, including methods and interpretation, were energetically keeping with the spirit of the Society's meetings in the past, the informal and relaxing setting created the ideal discussed. Controversies and discussions concerning the use of embryonic stem cells for therapeutic purposes atmosphere for open scientific exchange and discussion of cutting-edge research. This year's meeting set several also escalated during the past year. Issues surrounding the conduct of clinical trials using novel cellular and new records, owing both to the hard work of the officers and committees and to the increasing excitement in the molecular treatments for neurological diseases and disorders led to the recently published guidelines for stud-field of neural transplantation and repair. A record number of presentations (112), including 73 posters and 39 ies of human subjects developed by the Practice Committee of the ASNTR (9). platform presentations, were included. In addition, as one of the Society's missions is to foster participation This year's Bernard Sanberg Memorial Award for Brain Repair recipient was Jeffrey Kordower, for his of young investigators, a record number of student and postdoctoral travel awards (30) were given this year.
body of work in neurological diseases and his contributions to translational research into the clinical setting. The Education Committee had a daunting task in selecting representative student presentations from among the The Presidential Address, given by Roy Bakay, entitled "Translational research: the human factor," included many high-quality applications.
The content of this year's meeting underscored sig-some poignant and moving moments from his own personal experiences. We were reminded of underlying mo-nificant shifts in the direction of neural repair and transplantation research, as well as the increasing breadth of tivation for investigation in this field of research, which will hopefully translate to improved outcomes and ulti-the field. As in previous meetings, repair strategies in the nigrostriatal system and Parkinson's disease was an mately cures for many of the devastating neurological diseases and injuries that afflict humanity. area of considerable research focus. However, increasing interest and emphasis on CNS trauma and the poten-This special issue of Cell Transplantation reflects the breadth and scope of work presented at the 2001 ASNTR tial for transplantation and repair strategies to improve function after brain and spinal cord injury and ischemia meeting. The contributions were invited by members of the Program Committee selected from oral and poster led to the inclusion of several new sessions covering these topics at the recent meeting. In addition, the explo-sessions. The complete abstracts were published in Experimental Neurology 170(1), July 2001. Several of the sion in the field of stem cell biology in the past few years has opened the door to potentially improved articles describe novel approaches in improving outcomes in Parkinson's disease models. Baker et al. (1) sources of cells for repair of the CNS following injury or disease. This explosion is reflected in the contribu-tested the hypothesis that a second well-placed dopaminergic graft may promote improved recovery and restora-tions to this year's meeting, with over one third of the submitted abstracts involving either neural stem cells/ tion of function following a suboptimal initial graft. To test this, rats with unilateral 6-hydroxydopamine lesions progenitors or novel stem cell sources such as bone marrow and umbilical cord blood. An interesting and infor-received either a single medial striatal graft, simultaneous medial and laterally placed striatal grafts, or dual mative lecture by the keynote speaker, Ronald McKay, entitled "Building animals from stem cells" also re-grafts transplanted 6 weeks apart. Results indicated that both dual graft conditions improved behavioral recovery flected the Society's growing interest in this area. Gene therapy and trophic factor delivery were also key topics compared with a single graft, and that sequential grafting can improve dopaminergic cell survival. Duan and of this year's meeting, and it is likely that combination approaches will provide more complete strategies in the collaborators (5) explored the use of tauroursodeoxycholic acid (TUDCA), a taurine conjugated hydrophilic repair of the nervous system.
As expected in a rapidly growing field, this year's bile acid with antiapoptotic properties, to improve the survival of nigral grafts. In vitro studies indicated in-meeting was not without its controversies. During the past year, the first results from a placebo-controlled clin-creased tyrosine hydroxylase-positive cell survival and 182 SAGEN AND WHITTEMORE reduced apoptotic cells in TUDCA-treated cultures. sulted in improved behavioral outcomes and reduced infarct volume, but this did not appear to be mediated When included in cell suspension transplants in the 6-OHDA-lesioned striatum, TUDCA reduced apoptosis, entirely by GDNF as improvements were not blocked by GDNF antibodies. increase survival of grafted cells, and improved behavioral recovery. Subramanian et al. (10) utilized human
Reflective of the growing interest in stem cell sources in neural transplantation strategies, nearly half of the ar-retinal pigment epithelial (hRPE) cells as a potential source of dopamine in 6-OHDA-lesioned striatum. In ticles explore this topic. Three of the articles address the potential usefulness of umbilical cord blood as an alter-addition, some hRPE cells were attached to microcarriers to enhance cell survival and reduce the need for im-nate source of stem cells. Potential advantages include ease of collection, relative immaturity with increased munosuppression. The attached RPE cells appeared to result in the most prolonged behavioral improvements proliferative potential, and reduced risk of rejection. 13) initiated stud-GDNF was injected intrastriatally 5 weeks following a maximal nigrostriatal lesion to more closely resemble ies characterizing the morphology and fate of human umbilical cord blood cells following transplantation to fully developed Parkinson's disease. These findings suggest that a population of nigrostriatal dopaminergic neu-the developing rat brain. Cells from cryopreserved samples were transplanted into the subventricular zone of rons remain following the lesion even though they lack TH expression, and are capable of rescue and functional neonatal rats, in some cases following preincubation in retinoic acid and nerve growth factor to increase neural restoration.
Several articles also address consequences of and po-differentiation. Results indicated approximately 20% survival regardless of pretreatment, but increased migra-tential approaches to traumatic and ischemic injury to the brain and spinal cord. Willson and colleagues (12) tion and dispersion in the nonpretreated group. GFAPpositive cells and small numbers of β-tubulin-expressing describe changes in a family of receptor tyrosine kinases, EphA, expression following contusive spinal cord cells suggested that at least some of the transplanted human umbilical cord cells may differentiate into neural injury. These receptors and their ligands, the Ephrins, are thought to act via repulsive mechanisms to guide phenotypes. Lu and colleagues (7) explored the use of these cells in a rat traumatic brain injury model. Undif-growing axons to their appropriate targets during development. Results indicated that several EphA molecules ferentiated human umbilical cord cells were injected intravenously following traumatic brain injury. The au-are upregulated after spinal cord injury and suggest that these increases may result in an environment unfavor-thors observed reduced motor and neurological deficits in conjunction with migration into the injured brain pa-able for functional axonal regeneration in the spinal cord. Grumbles et al. (6) expanded on their previous renchyma and expression of neural markers. Tate and coworkers (11) describe a means of improv-findings that denervated skeletal muscles, as occurs after trauma or disease, can be rescued from atrophy by trans-ing the survival of neural stem cell suspension transplants by recapitulating a three-dimensional extracellular plantation of embryonic ventral spinal cord cells into nearby peripheral nerve. The possibility of further im-environment using a fibronectin-based matrix. Neural stem cells from green fluorescent protein-expressing mouse provements was explored by varying cell numbers in the transplants, adding NGF, or transplanting in predegener-brains were transplanted into injury cavities 1 week following traumatic brain injury. Results showed signifi-ated nerve. Results suggested that the transplantation of fewer cells without NGF and prior nerve degeneration cantly improved survival of transplanted cells injected into the cavity within a fibronectin matrix compared improves regeneration of large-diameter axons and reduces muscle atrophy. Dillon-Carter and collaborators with injections of cell suspensions alone. Castellanos et al.
(3) utilize neural stem cells genetically engineered (4) utilized fetal rat kidney cells immortalized using truncated fragments of the SV40 large T antigen as a to overexpress functional trkC receptors as a potential strategy in replacing synaptic target sites in the spinal source of GDNF in a rat stroke model. Clones producing GDNF at physiological concentrations were transplanted cord. Survival of these cells in the spinal cord was significantly improved following treatment with trkC ligand into the ischemic core or penumbra during middle cerebral artery occlusion. Three of four clones tested re-neurotrophin-3 (NT-3). In addition, increased migration 
